p53 Alterations Predict Tumor Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Series - Concepedia

Concepedia

Publication | Closed Access

p53 Alterations Predict Tumor Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Series

193

Citations

44

References

2000

Year

Arnauld Cabelguenne, Hélène Blons, Isabelle de Waziers, Françoise Carnot, Anne‐Marie Houllier, Thierry Soussi, Daniel Brasnu, Philippe Beaune, O. Laccourreye, Pierre Laurent‐Puig

Journal of Clinical Oncology

Abstract

This prospective study suggests that p53 status may be a useful indicator of response to neoadjuvant chemotherapy in HNSCC.

References

	Year	Citations
Toxicity and response criteria of the Eastern Cooperative Oncology Group Martin M. Oken, Richard H. Creech, Douglass C. Tormey, American Journal of Clinical Oncology Health SciencesMedicineCancer ManagementClinical EndpointPharmacology	1982	11.4K
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Marc S. Greenblatt, W P Bennett, Monica Hollstein, PubMed Tumor BiologyCancer PathologyMolecular PathogenesisMedicineCancer Cell Biology	1994	3.5K
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Scott W. Lowe, H. Earl Ruley, Tyler Jacks, Cell P53-dependent ApoptosisMedicineApoptosisPharmacologyCell Death	1993	2.9K
Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer New England Journal of Medicine	1991	2.7K
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations Yunje Cho, Svetlana S. Gorina, Philip D. Jeffrey, Science ChromatinCrystal StructureDna BindingStructural BioinformaticsBiomolecular Structure Prediction	1994	2.5K
<i>p53</i> Status and the Efficacy of Cancer Therapy in Vivo Scott W. Lowe, Stephan Bodis, Andrea I. McClatchey, Science Cancer TherapyP53 StatusApoptosisPathologyCell Death	1994	1.5K
Gain of function mutations in p53 Dirk P. Dittmer, Sibani Pati, Gerard P. Zambetti, Nature Genetics Genome InstabilityMolecular BiologyFunction MutationsCancer GeneticsMedicine	1993	895
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients Turid Aas, Anne‐Lise Børresen, Stephanie Geisler, Nature Medicine Breast OncologyBreast Cancer PatientsMedicinePathologyCancer Genomics	1996	737
Overexpression of Metallothionein Confers Resistance to Anticancer Drugs Susan L. Kelley, Alakananda Basu, Beverly A. Teicher, Science	1988	604
The incidence of p53 mutations increases with progression of head and neck cancer. Jay O. Boyle, J Hakim, Wayne M. Koch, PubMed Neck CancerPathologyNeck Squamous CarcinomaDermatologyTreatment Resistance	1993	601

Page 1